Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic Stock News stories for the week of April 6th – 12th, 2020.
Without further ado, let’s get started.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
* Yahoo Finance readers, please click here to view full article.
10. Champignon Brands to Acquire Health Canada Licensed Psychedelic Clinic Operator AltMed
AltMed Owns 75% of a Fully Operational Ketamine Clinic Located Near Toronto, Ontario
Champignon Brands (CSE:SHRM) (OTC:SHRMF) (FRA: 496) announced it has entered into a definitive agreement to acquire 100% of AltMed Capital Corp. AltMed is a preeminent Canadian Ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer. AltMed’s Psychedelics clinic is licensed by Health Canada to dose eligible patients with Psilocybin and is the only clinic in Canada able to perform Psilocybin doses under Health Canada approval.
READ FULL CHAMPIGNON BRANDS ARTICLE
Horizons ETFs Management (Canada) recently completed the quarterly rebalance of its cannabis-focused ETFs Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) and Horizons U.S. Marijuana Index ETF (NEO: HMUS). Following the rebalance, here’s what the two Cannabis ETFs look like now.
READ FULL CANNABIS ETFS ARTICLE
8. These Companies Plan to Use Psychedelic Medicine to End the Opioid Epidemic Once and For All
Thanks to recent advancements in psychedelic medicine, there’s renewed hope and optimism surrounding the deadly opioid epidemic. ATAI Life Sciences, DemeRx and MindMed (NEO: MMED) (OTC:MMEDF) (FRA: BGHM) are waging war against opioid addiction By utilizing this one little-known Psychedelic substance.
READ FULL OPIOID EPIDEMIC ARTICLE
7. Canntrust Confirms Delisting From NYSE, TSX
It seems that it’s all over for CannTrust Holdings (TSX:TRST) (NYSE:CTST) shareholders. The company confirmed within a news release that its equity will be delisted from the major exchanges, and that a cease trade order will remain on the equity.
6. Trulieve Reports Record Q4 Revenue, Reaffirms 2020 Guidance Despite COVID-19 Pandemic
Despite the Coronavirus Crisis, Trulieve Reaffirmed its Financial Guidance for 2020
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Trulieve (CSE:TRUL) (OTCQX:TCNNF) announced earnings this week for the fourth quarter and full fiscal year 2019. The top U.S. multi-state operator (MSO) posted 2019 total revenue of $252.8 million, up 145% year-over-year.
READ FULL TRULIEVE EARNINGS ARTICLE
5. Green Thumb Should Weather the COVID Storm Just Fine, says Echelon Wealth
The Analyst Has Put GTII into Echelon’s Top Picks Portfolio for the Second Quarter 2020
Look for leading U.S. multi-state operator (MSO) Green Thumb Industries (CSE:GTII) (OTCQX:GTBIF) (FRA: R9U2) to keep outperforming its peers in these tough market conditions, said Echelon Wealth Partners analyst Andrew Semple in a new report to clients.
4. 3 Ways the Cannabis Industry Will Come Out Stronger From the Coronavirus Pandemic
Next Year Could Look Quite Different for Many Cannabis Stocks
If 2019 was a tough year for the cannabis industry, 2020 could be downright catastrophic. However, as bad as things look today, the industry may get stronger as a result of the COVID-19 pandemic. Here are three ways the Marijuana Stocks may actually get stronger as a result of the coronavirus.
READ FULL CANNABIS INDUSTRY ARTICLE
3. 4 Canadian Pot Stocks Expected to Be Profitable in 2021
According to Wall Street, the following four Canadian Cannabis Stocks are on the fast track to becoming profitable in 2021: Organigram (TSX:OGI) (NASDAQ:OGI) (FRA: 0OG), Aphria (TSX:APHA) (NYSE:APHA) (FRA: 10E), MediPharm Labs (TSX:LABS) (OTCQX:MEDIF) (FRA: MLZ) and Valens (TSXV:VLNS) (OTCQX:VGWCF) (FRA: 7LV).
READ FULL PROFITABLE POT STOCKS ARTICLE
2. Trulieve Cannabis is an Industry Leader, says Beacon Securities
In an update to clients, Stanley reiterated his “Buy” rating and $36 target price, saying Trulieve (CSE:TRUL) (OTCQX:TCNNF) has one of the best balance sheets in the industry.
READ FULL TRULIEVE ANALYST ARTICLE
1. DEA Deschedules Expidiolex; GW Pharma’s CBD Epilepsy Treatment No Longer a Controlled Substance
GW Pharmaceuticals (NASDAQ:GWPH) (FRA: GW2A) confirmed it has obtained a notice from the Drug Enforcement Administration (DEA) certifying that its Epidiolex oral solution has been descheduled and is no longer a controlled substance.
Image by 7raysmarketing from Pixabay
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.